Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 8 at 2:00 PM EDT

Register Free →

Automated Cryptographic Bill of Materials (CBOM) Generation

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract seeks the design and implementation of a system capable of automatically generating structured, machine-readable Cryptographic Bill of Materials (CBOMs) from discovered cryptographic assets. This system must accurately inventory, classify, and document cryptographic components across distributed environments to enable precise risk reporting and strategic planning for post-quantum migration. The output must be standardized and consumable by automated tools used in cybersecurity governance, ensuring alignment with broader DoD cryptographic hygiene and transition objectives. This is a subcontract under the Department of Defense, specifically managed by Niwc Atlantic, with a NAICS code of 541714 indicating it falls under research and development in the physical, engineering, and life sciences. The solicitation was posted on June 30, 2026, with a response deadline of July 8, 2026, at 3:59 a.m. UTC. The work will be performed under the auspices of the DoD and is intended to directly support agency-wide efforts to map, assess, and remediate cryptographic vulnerabilities in preparation for quantum computing threats. No set-aside provisions or specific location details are provided, and the point of contact information is omitted from the published data.

General Info

Design and implement automated CBOM system for DoD cryptographic asset inventory and post-quantum migration readiness.

Agency

Department Of Defense → Niwc AtlanticView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

SC, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Niwc Atlantic
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → Niwc Atlantic
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Design and implement a system to generate structured, machine-readable CBOMs from discovered cryptographic assets to support risk reporting and post-quantum migration planning.

Similar Contracts

NAICS: 541714
New
Federal
Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) - TA3The RAPIID program, specifically Task Area 3, aims to bridge the gap between lab-scale breakthroughs in shelf-stable blood analogs and real-world deployment by advancing the regulatory approval, manufacturing scalability, and field usability of components originally developed under the FSHARP program. These components, designed to replicate the critical functions of whole blood—oxygen delivery, hemostasis, and volume expansion—now require rigorous clinical validation to demonstrate safety and efficacy when used in combination, as well as scalable production processes to ensure consistent, high-volume output. Efforts under this solicitation will focus on pushing these technologies through the regulatory pathway to secure necessary approvals for military and civilian use in austere, pre-hospital environments. The initiative seeks to develop and scale enabling fielding technologies that support the deployment, storage, and administration of these blood analogs outside controlled laboratory settings. This includes not only the components themselves but also the logistical and operational frameworks needed to integrate them into frontline medical workflows. Proposals must address the full spectrum of challenges—from manufacturing robustness and regulatory compliance to usability in extreme conditions—while aligning with the program’s goal of delivering a complete, authorized system capable of saving lives where traditional blood supplies are unavailable. The solicitation, issued by DARPA’s Biological Technologies Office, has a response deadline of July 29, 2026, and is open to all qualified entities, targeting the NAICS code 541714 for research and development in physical, engineering, and life sciences.
Defense Advanced Research Projects Agcy

POSTED

2 days ago

DEADLINE

in 25 days
View Details
NAICS: 541714
New
Federal
RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)The Biomedical Advanced Research and Development Authority (BARDA), under the U.S. Department of Health and Human Services, is seeking proposals through Request for Proposal 75A50126R00002 to advance the late-stage clinical development and regulatory approval of 2-PAM autoinjectors as a drug/device combination product for the treatment of organophosphate poisoning, including nerve agents, in both adult and pediatric populations. The contract also encompasses the procurement of these autoinjectors for inclusion in the Strategic National Stockpile (SNS) and CHEMPACK programs. The solicitation requires offerors to demonstrate the capability to manufacture 600 mg 2-PAM autoinjectors at a Phase 3 clinical level or higher, with full FDA approval readiness. Proposals must include a comprehensive technical approach covering risk mitigation, project management, inventory control, and post-market surveillance, with mandatory compliance with current Good Manufacturing Practices and FDA guidance for emergency use or approved medical products. The contract features a base period of up to 36 months with up to three optional periods extending performance to a total of 10 years, involving a total potential procurement of 2 million adult-dose autoinjectors across four separate firm-fixed-price line items, each for 500,000 units, supported by cost-plus-fixed-fee line items for development and post-market activities. Deliveries are FOB destination to BARDA’s facility in Washington, D.C., with the contractor responsible for product integrity, temperature control (8–25°C), and security—including GPS tracking, tamper-resistant sealing, and TempTale documentation—until formal government acceptance. Evaluation is conducted on a best-value trade-off basis, with mandatory technical and infrastructure criteria serving as disqualifying thresholds, followed by technical approach, past performance, and cost. Offerors must be current in SAM with a valid UEI and CAGE code, and are subject to strict organizational conflict of interest disclosures, key personnel notification requirements, and prohibitions on the use of funds for abortions, needle distribution for illegal drug use, or human embryo research. Proposals must be submitted electronically via the BDR Portal by July 30, 2026, structured in three distinct volumes under strict page limits, with compliance to HHSAR and FAR clauses governing supply chain risk, anti-lobbying, and inspection standards.
Barda - Aspr / Daappo / Barda Dcma

POSTED

2 days ago

DEADLINE

in 26 days
View Details
NAICS: 541714
New
Grant
NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)The National Institutes of Health, through the National Institute of Diabetes and Digestive and Kidney Diseases, is inviting applications for Disease Research and Translational Core Centers under the P30 mechanism, which is clinical trial optional. These centers aim to strengthen existing research institutions with established programs in cystic fibrosis, diabetes, nutrition, obesity, liver, and digestive diseases by fostering multidisciplinary collaboration, improving research rigor and reproducibility, and enhancing cost efficiency. The centers are structured around shared core services that provide access to specialized equipment, technical resources, analytical support, and expert-led training, all tailored to the specific needs of the research community within the institution. They also include a Pilot and Feasibility Grant Program to support new projects and a Scientific Catalyst Program administered through the Administrative Core, which promotes team building, mentoring, workshops, seminars, and visits by expert scientists to stimulate innovation and attract new investigators to the field. The program places strong emphasis on creating a nurturing environment for trainees and early-stage investigators, ensuring that emerging researchers benefit from mentorship and integrated scientific networks. Core services must be operated or overseen by recognized experts and are designed to be shared across center members to maximize impact and efficiency. The Scientific Catalyst Program specifically supports activities that build research capacity, encourage cross-disciplinary partnerships, and align scientific efforts with the center’s focus on chronic diseases. Applications are expected to demonstrate how the proposed infrastructure will enhance existing strengths and expand the institute’s research trajectory. The funding opportunity was posted on July 2, 2026, and inquiries should be directed to the designated NIDDK contact for further details.
National Institutes Of Health

POSTED

3 days ago

DEADLINE

N/A
View Details